Skip to main content
Figure 1 | BMC Neurology

Figure 1

From: The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

Figure 1

Results of skin examination at the first evaluation. The number of patients experiencing ISRs at the first evaluation was recorded for each therapy. At the first evaluation examination, patients had been on their current DMT for at least 2 years. *P < 0.0001 vs IM IFNβ-1a; chi-square test. † P = 0.016 vs SC IFNβ-1b; P < 0.001 vs SC IFNβ-1a; P = NS vs IM IFNβ-1a; chi-square test.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us